Neeraja Idamakanti,
Principal Scientist,
Takeda Pharmaceuticals
Neeraja Idamakanti is Principal Scientist in the department of Drug Safety Research & Evaluation at Takeda. Neeraja’s main focus is investigative immunotoxicology. She is involved in developing de-risking strategies for molecules potential to cause immunotoxicity. Her interests include; cell biology, immunology, virology, genetherapy and immunotherapy. Before joining Takeda, Neeraja worked at Novartis for over 10 years. She obtained her BVSc (DVM) in Veterinary medicine from India and later she received MS in molecular virology from veterinary school at university of Saskatchewan, Canada.
|
|
|
Add to Calendar ▼2020-08-19 00:00:002020-08-20 00:00:00Europe/London2D-to-3D Culture and Organoids 20202D-to-3D Culture and Organoids 2020 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
